Search research articles
Contact Us
Filters
Showing results (41-50 of 70) with videos related to
Page
of 7
Sort By:
Human Gene Therapy
|
April 16, 2021
Intracerebroventricular Administration of AAV9-PHP.B SYN1-EmGFP Induces Widespread Transgene Expression in the Mouse and Monkey Central Nervous System
Adriana Galvan, Terri L Petkau, Austin M Hill, et al.
Molecular Therapy. Methods & Clinical Development
|
April 8, 2020
Germline CRISPR/Cas9-Mediated Gene Editing Prevents Vision Loss in a Novel Mouse Model of Aniridia
Seyedeh Zeinab Mirjalili Mohanna, Jack W Hickmott, Siu Ling Lam, et al.
Ophthalmology and Therapy
|
May 20, 2023
ABE8e Corrects Pax6-Aniridic Variant in Humanized Mouse ESCs and via LNPs in Ex Vivo Cortical Neurons
Bethany A Adair, Andrea J Korecki, Diana Djaksigulova, et al.
Genesis (New York, N.Y. : 2000)
|
July 23, 2003
Metaphase FISHing of transgenic mice recommended: FISH and SKY define BAC-mediated balanced translocation
Brett S Abrahams, Annabelle C O Chong, Maimun Nisha, et al.
Genomics
|
June 25, 2002
Novel vertebrate genes and putative regulatory elements identified at kidney disease and NR2E1/fierce loci
Brett S Abrahams, Grace M Mak, Melissa L Berry, et al.
Developmental Biology
|
October 10, 2006
Hippi is essential for node cilia assembly and Sonic hedgehog signaling
Caroline Houde, Robin J Dickinson, Vicky M Houtzager, et al.
Behavioural Brain Research
|
May 9, 2002
Fierce: a new mouse deletion of Nr2e1; violent behaviour and ocular abnormalities are background-dependent
Kelly A Young, Melissa L Berry, Connie L Mahaffey, et al.
Gene Therapy
|
February 3, 2021
Human MiniPromoters for ocular-rAAV expression in ON bipolar, cone, corneal, endothelial, Müller glial, and PAX6 cells
Andrea J Korecki, Jorge L Cueva-Vargas, Oriol Fornes, et al.
Molecular Vision
|
December 6, 2012
Absence of NR2E1 mutations in patients with aniridia
Ximena Corso-Díaz, Adrienne E Borrie, Russell Bonaguro, et al.
Neurobiology of Disease
|
April 28, 2026
Humanized mice carrying a pathogenic GRN deletion as a pre-clinical platform for targeted gene therapies in frontotemporal dementia
Benjamin E Life, Pardis Kazemian, Terri L Petkau, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 70) with videos related to
Sort By:
Page
of 7
Human Gene Therapy
|
April 16, 2021
Intracerebroventricular Administration of AAV9-PHP.B SYN1-EmGFP Induces Widespread Transgene Expression in the Mouse and Monkey Central Nervous System
Adriana Galvan, Terri L Petkau, Austin M Hill, et al.
Molecular Therapy. Methods & Clinical Development
|
April 8, 2020
Germline CRISPR/Cas9-Mediated Gene Editing Prevents Vision Loss in a Novel Mouse Model of Aniridia
Seyedeh Zeinab Mirjalili Mohanna, Jack W Hickmott, Siu Ling Lam, et al.
Ophthalmology and Therapy
|
May 20, 2023
ABE8e Corrects Pax6-Aniridic Variant in Humanized Mouse ESCs and via LNPs in Ex Vivo Cortical Neurons
Bethany A Adair, Andrea J Korecki, Diana Djaksigulova, et al.
Genesis (New York, N.Y. : 2000)
|
July 23, 2003
Metaphase FISHing of transgenic mice recommended: FISH and SKY define BAC-mediated balanced translocation
Brett S Abrahams, Annabelle C O Chong, Maimun Nisha, et al.
Genomics
|
June 25, 2002
Novel vertebrate genes and putative regulatory elements identified at kidney disease and NR2E1/fierce loci
Brett S Abrahams, Grace M Mak, Melissa L Berry, et al.
Developmental Biology
|
October 10, 2006
Hippi is essential for node cilia assembly and Sonic hedgehog signaling
Caroline Houde, Robin J Dickinson, Vicky M Houtzager, et al.
Behavioural Brain Research
|
May 9, 2002
Fierce: a new mouse deletion of Nr2e1; violent behaviour and ocular abnormalities are background-dependent
Kelly A Young, Melissa L Berry, Connie L Mahaffey, et al.
Gene Therapy
|
February 3, 2021
Human MiniPromoters for ocular-rAAV expression in ON bipolar, cone, corneal, endothelial, Müller glial, and PAX6 cells
Andrea J Korecki, Jorge L Cueva-Vargas, Oriol Fornes, et al.
Molecular Vision
|
December 6, 2012
Absence of NR2E1 mutations in patients with aniridia
Ximena Corso-Díaz, Adrienne E Borrie, Russell Bonaguro, et al.
Neurobiology of Disease
|
April 28, 2026
Humanized mice carrying a pathogenic GRN deletion as a pre-clinical platform for targeted gene therapies in frontotemporal dementia
Benjamin E Life, Pardis Kazemian, Terri L Petkau, et al.
Page
of 7